Robust predictors for drug response of patients with acute myeloid leukemia
Fig 3
Visualization of the three cohorts, Beat AML waves 1 + 2, Beat AML waves 3 + 4 and Functional Precision Medicine Tumor Board (FPMTB), based on the first two principal components.
Beat AML dataset, Waves 1 + 2 (371 samples), Waves 3 + 4 (184 samples) has been processed with the same library, SureSelect Strand-Specific RNA Library (Agilent), while the FPMTB (163 samples) dataset which have been processed with different libraries, i.e., NextEra and Scriptseq.